Cathie Wood’s ARK ETFs Make Significant Moves: Buying CRISPR, BWXT, and Amazon, Selling Unity and Rocket Lab

Cathie Wood, the founder of Ark Investment Management, has been making noteworthy moves in the stock market through her exchange-traded funds (ETFs). On Thursday, November 14, 2024, ARK ETFs published their daily trades, revealing a series of strategic buy and sell actions across various sectors.

One of the most significant purchases was in CRISPR Therapeutics AG (NASDAQ:CRSP), with ARK acquiring 178,062 shares across the ARKK and ARKG ETFs, amounting to an $8,865,707 investment. This move highlights ARK’s growing interest in the gene-editing company, which has seen consistent buying activity in recent days.

Another notable buy was in BWX Technologies Inc (NYSE:BWXT), with ARK purchasing 14,779 shares through its ARKQ ETF, translating to an investment of $1,952,453. This purchase aligns with ARK’s focus on innovative industrial companies.

ARK ETFs also made substantial purchases in other companies, including Archer Aviation Inc (NYSE:ACHR), Amazon.com Inc (NASDAQ:AMZN), Blade Air Mobility Inc (NASDAQ:BLDE), and Joby Aviation Inc (NYSE:JOBY). For example, ARK bought 28,509 shares of Amazon across three ETFs, totaling $6,103,777.

On the sell side, ARK divested significant portions of its holdings in Roblox Corp (NYSE:RBLX) and Rocket Lab USA Inc (NASDAQ:RKLB), with sales totaling $8,222,245 and $11,821,003, respectively. Additionally, ARK sold 2,287,064 shares of Unity Software (NYSE:U) over four consecutive trading days, cashing in for $48 million. This sale follows Unity’s Q3 earnings report, which saw revenue and adjusted profit beating expectations despite a year-over-year decline.

These transactions reflect ARK’s tactical adjustments and ongoing commitment to investing in disruptive innovation. Investors are closely monitoring these trades as they may indicate broader trends and shifts within ARK’s investment focus).